Novogene company: Product of Identification of virus siRNA

Abstract

Introduction Novogene Bioinformatics Technology Co.,Ltd was founded in March, 2011, in Beijing Life Science Park. Exclusively focusing on genome research and bioinformatics development, Novogene aims to distinguish it as one of the world’s leading genomic solution providers. Recently, more and more results show that high throughout small RNA sequencing has used to identify unknown virus and viroid in host. As Virus small RNA molecular overlaps from each other, contigs can be assembled to genome sequence. High throughout small RNA sequencing has been a rapid virus identification method, which not involves isolated culture and enrichment of virus and greatly cut down the period. The technology has widely applied to the pathogen monitoring with insect-borne infectious disease and authentication, test or the whole genome sequencing of animals and plant virus, etc. Technological advantage Convenient sample collection : no isolated culture,extract total RNA of virus infection tissue directly. No reference sequence: identification virus without host reference sequence. Accurate and reliable: Experimental verification rate has reach more than 80%.